The FDA has authorized a prescription ivermectin liquid for short-term prevention of New World screwworm in certain horses. The July 15 action is narrow: it applies within 24 hours of birth or at initial wound care, may protect for no more than 24 hours, and does not authorize treatment of an existing infestation.
By Jon Conklin | Published July 20, 2026 | Updated July 21, 2026
What changed?
On July 15, 2026, the U.S. Food and Drug Administration issued an Emergency Use Authorization for Ivermectin Liquid for Horses, an ivermectin oral solution available only by prescription. FDA authorized it for short-term prevention of New World screwworm myiasis when given to a newborn foal within 24 hours of birth or to a horse of any age at the time of initial wound care. The authorization is not approval, is not a routine barn-wide prevention instruction, and is not authorization to treat an infested wound.
Why this matters now
New World screwworm larvae feed on living tissue. Flies are attracted to open wounds and healing umbilical areas, which puts newborn foals, injured horses, recent surgical patients, and horses with fresh procedure sites at particular risk when the parasite is present.
The federal action gives veterinarians another tool during the 2026 U.S. response, but it also creates a predictable danger: horse owners may hear “ivermectin” and assume an ordinary tube on the tack-room shelf is interchangeable. It is not.
The FDA authorization applies to a specific ready-to-use oral solution, specific timing, a specific species, and specific conditions of use. The product requires a prescription from a licensed veterinarian and may be administered as an oral drench or through a nasogastric tube. Nasogastric administration is a veterinary procedure.
What the authorization does not mean
-
It does not treat an existing screwworm infestation. If larvae are present or an infestation develops after administration, contact a veterinarian immediately.
-
It does not turn every ivermectin product into an authorized substitute. Do not improvise with paste, injectable, pour-on, livestock, or other formulations.
- It is not intended as routine prevention for healthy horses without wounds or an expectation of a wound.
-
It is not full FDA approval. An EUA uses a different evidence standard and remains tied to the federal emergency declaration.
- It does not replace wound coverage, repellents, fly control, daily inspection, reporting, or veterinary care.
What FDA says about the evidence
FDA states that it is reasonable to believe the authorized ivermectin liquid may be effective when used under the authorization and that its known and potential benefits outweigh its known and potential risks.
That is not the same as proof from clinical trials in horses. In its July 15 letter to horse owners and veterinarians, FDA said there are no horse clinical data directly demonstrating that either currently authorized horse product prevents New World screwworm myiasis. The agency also said the oral ivermectin formulation has not been directly tested against New World screwworm in horses.
FDA estimates that the ivermectin liquid may provide protection for up to 24 hours after one dose. Wounds expected to remain open and vulnerable need additional barriers and fly-control measures directed by a veterinarian.
Plain-English distinction: emergency authorization means FDA has determined that the product may be effective and that the potential benefit outweighs the potential risk under the authorized conditions. It does not mean the product has completed the full approval process.
There are two prevention options under federal emergency authorization
The new action covers prescription Ivermectin Liquid for Horses. FDA also identifies Dectomax/Dectomax-CA1, a doramectin injection, as an emergency-authorized prevention option for horses one year of age or older when used at wound appearance or castration under its directions.
These are not interchangeable decisions. FDA notes that horses have a narrower safety margin than some other species, and its safety discussion for doramectin includes adverse effects at doses above the authorized amount. The right product, timing, route, and risk-benefit decision belong with a veterinarian and the current FDA materials.
What horse owners should do next
1. Call before dosing
If a foal has just been born, a horse has a fresh wound, or a procedure site may remain vulnerable, call your veterinarian before administering any product for screwworm prevention. Ask whether the horse fits an authorized use and which current option, if any, is appropriate.
2. Inspect wounds at least daily
Pay special attention to foal navels, fresh cuts, punctures, castration and surgery sites, tack rubs, pastern lesions, coronary-band injuries, and wounds found before or after hauling. Moving larvae, rapid tissue loss, foul odor, bloody drainage, marked pain, or heavy fly concentration requires urgent veterinary attention.
3. Do not delay reporting
A suspicious wound is not a routine home-care problem. Stop unnecessary movement, use gloves, keep supplies dedicated to the horse, and call your veterinarian. Follow instructions before aggressively cleaning the site or discarding larvae that officials may need for identification.
4. Use an integrated fly and wound plan
Medication cannot protect an open wound by itself. Follow veterinary direction for cleaning and bandaging, reduce fly pressure, manage manure and wet organic matter, and use only appropriately labeled repellents or barriers on suitable areas. Never pour ordinary fly products or harsh home remedies into open tissue.
5. Check current travel information
Before hauling, review Screwworm.gov and current destination requirements. Use the Regional Horse Care guide for broader travel and seasonal planning, and keep the Horse Health Library available for practical care references.
Draw It Out® analysis
The useful headline is not “ivermectin stops screwworm.” That is too broad and could push owners toward the wrong formulation, timing, or horse.
The real change is narrower and more important: veterinarians now have a prescription oral option for a short prevention window when a horse is especially vulnerable. The practical response is still built on early wound recognition, clean records, controlled movement, physical barriers, fly management, and fast veterinary contact.
Federal emergency tools matter. So does resisting the urge to turn a narrow authorization into barn folklore.
The bottom line
FDA’s July 15 authorization expands the response to New World screwworm, but it does not create a do-it-yourself protocol. The prescription ivermectin liquid is authorized only for short-term prevention within 24 hours of birth or at initial wound care. It may protect for no more than 24 hours, has not been directly tested against screwworm in horses, and cannot be used to treat an established infestation.
If a horse has a vulnerable wound, talk with your veterinarian. If larvae or rapid tissue damage are present, treat it as urgent and report it through the veterinary and animal-health chain.
Commercial disclosure: Draw It Out® publishes Horse Health Care News and sells equine-care products. No Draw It Out® product is promoted or recommended to prevent, diagnose, or treat New World screwworm.
Veterinary notice: This report is educational and does not replace examination, diagnosis, treatment, prescription instructions, reporting requirements, quarantine directions, or current federal and state animal-health guidance.
